Q&A
CJC-1295 Ipamorelin: Common Questions, Answered from the Research
Direct, cited answers to what people most often ask — timelines, side effects, comparisons, and regulatory status.
How long for CJC-1295 / Ipamorelin to work / show results?
The biological signal starts fast and lasts long. A single subcutaneous dose of CJC-1295 (DAC) raised mean plasma GH 2- to 10-fold for six days or more and IGF-1 1.5- to 3-fold for 9 to 11 days in healthy adults; after multiple doses IGF-1 stayed above baseline up to 28 days [1]. Reported subjective effects like better sleep are described within one to two weeks, anecdotally.
What is CJC-1295 / Ipamorelin good for?
In research terms, it's built to raise growth hormone and IGF-1: CJC-1295 (DAC) sustained GH and IGF-1 elevation for days in healthy adults [1], and ipamorelin adds a clean, selective GH pulse [2]. Downstream, people report better sleep, recovery, and gradual leanness — anecdotal, not proven for the blend. Animal data show GH-driven bone growth [8].
What are the bad side effects of CJC-1295 and Ipamorelin?
The class's most consistent concern is raised blood glucose from reduced insulin sensitivity [6]. GH-related fluid retention, puffiness, carpal-tunnel-like tingling, and joint aches are mechanistically expected. Ipamorelin itself is notably clean — unlike older GHRPs it did not raise cortisol or ACTH even at very high doses [2]. Community reports add injection-site reactions and post-dose flushing.
How long do CJC-1295 and Ipamorelin take to work?
Pharmacologically, fast: CJC-1295 (DAC) raised GH 2- to 10-fold for six or more days and IGF-1 for 9 to 11 days after one subcutaneous dose, with IGF-1 above baseline up to 28 days after repeat dosing [1]. Subjective changes such as improved sleep are reported in the first one to two weeks, but those reports are anecdotal, not trial data.
How many mg of CJC-1295 and Ipamorelin should I take?
This digest gives no human dosing. Research recorded specific study doses — for example, CJC-1295 at 30 or 60 micrograms per kilogram subcutaneously in healthy-adult PK work [1], and ipamorelin dosing largely in rats [9][10] — but those are study figures for specific species, not recommendations. There is no published human dose for the fixed combination.
Does CJC-1295 raise testosterone?
CJC-1295 acts on the growth-hormone axis, not the testosterone axis: it raises GH and IGF-1 [1], not luteinizing hormone or testosterone directly. The literature here is about GH and IGF-1 elevation. Any effect on testosterone is not an established finding in the cited research, so this digest doesn't claim one.
Does Ipamorelin reduce belly fat?
Not proven for ipamorelin in humans. The strongest body-composition evidence in this family belongs to the GHRH analogue tesamorelin: a 2026 meta-analysis of five trials found significant visceral-fat reduction (-27.71 square centimeters) and hepatic-fat reduction (-4.28%) [7]. Ipamorelin's fat-loss effects are anecdotal in humans, and one mouse study even showed a GH-independent fat-gain pathway.
What are the downsides to CJC-1295 / Ipamorelin?
The honest downsides: the fixed blend has never been trialed in humans, so efficacy and long-term safety for it are unestablished [14]. Mechanistically, raising GH can elevate blood glucose [6] and cause fluid retention and carpal-tunnel-like symptoms. Neither peptide is FDA-approved, both are WADA-prohibited, and research-grade purity from unregulated suppliers is unverified.
Which is better, Sermorelin or Ipamorelin?
They aren't rivals — they're different arms. Sermorelin is a GHRH analogue; ipamorelin is a GHRP acting on the ghrelin receptor [2]. A GHRH and a GHRP stimulate GH through independent mechanisms and add up to more together than alone [3]. So they're typically combined, not chosen between; "better" depends on whether you mean the GHRH arm or the GHRP arm.
Can you take both Sermorelin and Ipamorelin together?
Combining a GHRH analogue with a GHRP is the whole logic of this class. In normal men, submaximal GHRP doses combined with GHRH stimulated GH release synergistically, the two acting through independent mechanisms [3]. Sermorelin (a GHRH analogue) plus ipamorelin (a GHRP) is mechanistically the same pairing as CJC-1295 plus ipamorelin. This digest describes that research; it gives no dosing.
Is Tesamorelin better than Ipamorelin?
For human evidence, tesamorelin is far better characterized: a 2026 meta-analysis of five randomized trials showed reduced visceral and hepatic fat, increased lean mass and IGF-1, and a manageable safety profile [7]. But tesamorelin is a GHRH analogue and ipamorelin is a GHRP — different arms. Tesamorelin has the stronger human data; ipamorelin contributes the selective GHRP pulse.
Is Ipamorelin stronger than Sermorelin?
"Stronger" isn't the right axis, because they act on different receptors — ipamorelin on the ghrelin receptor, sermorelin on the GHRH receptor [2]. What ipamorelin is notable for is cleanliness: as the first selective GH secretagogue it released GH without raising cortisol or ACTH even at very high doses [2]. The two are designed to complement, not to outdo, each other.
Which is safer, Sermorelin or Ipamorelin?
Both are GH secretagogues and share the class's profile — generally well tolerated short-term, with raised blood glucose the chief concern [6]. Ipamorelin's distinguishing safety feature is selectivity: unlike older GHRPs it did not raise ACTH or cortisol even at doses over 200 times the GH-releasing amount [2]. Neither is FDA-approved, and long-term human safety data are lacking for both.
What is CJC-1295 / Ipamorelin?
It's a research combination of two peptides: CJC-1295, a long-acting GHRH analogue (the "release" signal for growth hormone), and ipamorelin, a selective GHRP that hits the ghrelin receptor. Used together they amplify the body's own GH pulse through two independent pathways [3][4]. Neither is FDA-approved, and the fixed combination has never been clinically trialed.
How much CJC-1295 / Ipamorelin should I take?
No human dose is provided here — this is an editorial research digest, not medical guidance. The literature records study doses (CJC-1295 at 30 to 90 micrograms per kilogram in early human PK work [1]; ipamorelin mostly in rodents [9][10]), but those are specific study figures for specific species, not recommendations, and there's no published human dose for the combination.
Is CJC-1295 / Ipamorelin safe?
Short-term, the GH-secretagogue class is generally well tolerated, with raised blood glucose the main concern [6], and ipamorelin is unusually clean among GHRPs [2]. But the fixed combination has never been studied in a controlled human trial, long-term safety data are lacking, and neither peptide is FDA-approved — so "safe" can't be claimed for the blend itself [14].
Does CJC-1295 / Ipamorelin work?
It demonstrably raises GH and IGF-1: CJC-1295 (DAC) sustained GH (2- to 10-fold) and IGF-1 elevation for days in healthy adults [1], and a GHRH-plus-GHRP combination raises GH synergistically [3]. Whether that produces the downstream sleep, recovery, and fat-loss benefits people want is unproven for the fixed blend — those reports are anecdotal.
Is Ipamorelin FDA approved?
No. Ipamorelin is not approved by the FDA for any human indication; it is sold only as a research chemical. It was investigated (including a postoperative-ileus program) but never advanced to approval. A 2018 review frames the GH-secretagogue class as generally well tolerated short-term while stressing that long-term safety data are still needed [6].
How to reconstitute CJC-1295 / Ipamorelin (5mg)?
This digest gives no preparation instructions. As laboratory-handling context: lyophilized (freeze-dried) research peptides are reconstituted with bacteriostatic water (sterile water with 0.9% benzyl alcohol), kept refrigerated at 2 to 8 degrees Celsius, and protected from agitation and freeze-thaw; aqueous solutions degrade over weeks via deamidation. That is general context for the class, not a how-to for human use.
Where to inject CJC-1295 / Ipamorelin?
No injection guidance is provided here. The studies recorded subcutaneous and intravenous routes, with subcutaneous most common in the human CJC-1295 PK work [1]. That describes how the research administered the compounds in specific protocols — it is not direction for personal use, which falls outside any studied protocol.
Does Ipamorelin make you hungry / increase appetite?
Increased appetite is commonly reported, and there's a clear mechanism: ipamorelin acts on the ghrelin receptor, and ghrelin is the body's hunger signal. Community accounts describe a noticeable uptick in hunger shortly after dosing, generally milder than with GHRP-6. The ghrelin-agonist class is well documented affecting GI function broadly [12]; the appetite reports themselves are anecdotal.
Can I take CJC-1295 / Ipamorelin in the morning?
This digest doesn't advise timing, because it gives no usage protocol. Research context: CJC-1295 (DAC) has a multi-day half-life, so its GH/IGF-1 effect spans days regardless of clock time [1], while ipamorelin produces a short pulse cleared within hours [2]. Community write-ups often favor pre-bed dosing to align with GH's natural overnight rhythm — that's anecdotal preference, not a finding.